CITIUS ONCOLOGY, INC. Quarterly Return On Equity in % from Q4 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Citius Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q4 2024.
  • Citius Oncology, Inc. Return On Equity for the quarter ending December 31, 2024 was -113 %, a 309% decline year-over-year.
  • Citius Oncology, Inc. annual Return On Equity for 2024 was -133 %, a 768% decline from 2023.
  • Citius Oncology, Inc. annual Return On Equity for 2023 was 20 %, a 380% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -113 -85.1 -309% Oct 1, 2024 Dec 31, 2024
Q3 2024 -133 Jul 1, 2024 Sep 30, 2024
Q2 2024 -35.8 Apr 1, 2024 Jun 30, 2024
Q1 2024 -30.3 Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.6 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.